Clinical Trial Update: Study of Immunological Memory Induced in Children by a Full 4 Dose Vaccination Schedule of 11 Valent Pneumococcal Conjugate Vaccine by Giving 1 Dose of Aventis Pasteur's 23-valent Pneumococcal Polysaccharide Vaccine (Pneumo 23) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating immunological memory in children after a four-dose schedule of an 11-valent pneumococcal conjugate vaccine with a single dose of Aventi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• 11-valent pneumococcal conjugate vaccine (pneumococcal conjugate vaccine, 11-valent)
• Pneumo 23 (Pneumococcal polysaccharide vaccine 23-valent)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Prophylaxis Pneumococcal Vaccine | Phase 3 | Status: COMPLETED